ABB-201

N/A

Report date: 2025/05/26 16:48:20

Base Information

Drug NameABB-201
Drug Alias NameABB-201
ClassificationBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRespiratory Distress Syndrome, Adult
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbbreos Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbreos Inc
Active IndicationsN/A
Inactive IndicationsRespiratory Distress Syndrome, Adult

Other Information

ATC CodeN/A
Related LinksN/A